BVF Partners OS Ltd.'s Net Worth

$0

Estimate Recalculated Feb 10, 2025 11:26PM EST

Who is BVF Partners OS Ltd.

BVF Partners OS Ltd. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Allakos Inc., Rain Therapeutics Inc., IMMUNE DESIGN CORP., Oncothyreon Inc., XOMA Corp, Xenon Pharmaceuticals Inc., Cullinan Oncology, Inc., Merus N.V., Nivalis Therapeutics, Inc., Repare Therapeutics Inc., PIERIS PHARMACEUTICALS, INC., Verastem, Inc., Syndax Pharmaceuticals Inc, CTI BIOPHARMA CORP, IDEAYA Biosciences, Inc., CYTOKINETICS INC, Kymera Therapeutics, Inc., Calithera Biosciences, Inc., CONCERT PHARMACEUTICALS, INC., CytomX Therapeutics, Inc., MoonLake Immunotherapeutics, GLYCOMIMETICS INC, Principia Biopharma Inc., INFINITY PHARMACEUTICALS, INC., Eledon Pharmaceuticals, Inc., Olema Pharmaceuticals, Inc., Regulus Therapeutics Inc., ESSA Pharma Inc., 4D Molecular Therapeutics, Inc., Third Harmonic Bio, Inc., FIVE PRIME THERAPEUTICS, INC., Structure Therapeutics Inc., ARQULE INC, enGene Holdings Inc., and POINT Biopharma Global Inc..

SEC CIK

BVF Partners OS Ltd.'s CIK is 0001660684

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Allakos Inc.

Investor
Updated Jan 26, 2024
Form 3
Jan 26, 2024
16.31M
Showing 1 results

Rain Oncology Inc.

Investor
Updated Jan 29, 2024
Form 4
-100.00%
-8.63M
Jan 29, 2024
Disposition
Jan 25 - Jan 26
Form 4
47.80%
1.71M
$5.83
$9.97M
Nov 10, 2022
8.60M
Purchase
Nov 08
Form 4
20.43%
557.73K
$12.00
$6.69M
Jan 10, 2022
6.87M
Purchase
Jan 06 - Jan 07
Form 4
0.41%
11.03K
$13.94
$153.83K
Sep 23, 2021
6.31M
Purchase
Sep 21
Form 4
16.86%
392.27K
$16.49
$6.47M
Sep 15, 2021
6.30M
Purchase
Sep 13
Form 4
33.73%
587.00K
$15.47
$9.08M
Jul 06, 2021
5.91M
Purchase
Jul 01 - Jul 06
Form 4
7.63%
123.35K
$15.94
$1.97M
May 25, 2021
5.32M
Purchase
May 21 - May 24
Form 4
14.80%
208.47K
$16.59
$3.46M
May 20, 2021
5.20M
Purchase
May 18 - May 19
Form 4
4.30%
58.00K
$14.26
$827.17K
May 17, 2021
4.99M
Purchase
May 13
Form 4/A
522.18%
1.13M
$16.86
$19.10M
May 17, 2021
1.35M
Purchase
Apr 23 - Apr 26
Form 4
29.86%
1.13M
$16.86
Apr 27, 2021
4.93M
Options
Apr 23 - Apr 26
Form 3
Apr 27, 2021
Showing 12 results

IMMUNE DESIGN CORP.

Investor
Updated Dec 04, 2018
Form 4
-15.77%
-902.00K
$1.83
-$1.65M
Dec 04, 2018
4.82M
Sale
Dec 04
Form 3
Nov 09, 2018
5.72M
Showing 2 results

Cascadian Therapeutics, Inc.

Investor
Updated Jun 27, 2016
Form 4
17.25K
$800.00
$13.80M
Jun 27, 2016
23.83M
Grant
Jun 23
Form 3
Dec 22, 2015
18.80M
Showing 2 results

XOMA Corp

Investor
Updated May 19, 2023
Form 4
10.97K
May 19, 2023
3.91M
Grant
May 17
Form 4
0.66%
22.25K
$19.15
$420.74K
Jan 09, 2023
3.90M
Purchase
Jan 05 - Jan 06
Form 4
0.73%
24.64K
$16.61
$409.31K
Sep 27, 2022
3.88M
Purchase
Sep 23 - Sep 27
Form 4
1.70%
56.31K
$17.70
$990.72K
Sep 16, 2022
3.85M
Purchase
Sep 14 - Sep 16
Form 4
9.00K
May 20, 2022
3.80M
Grant
May 18
Form 4
5.10K
May 21, 2021
3.79M
Grant
May 19
Form 4
-15.58%
-651.70K
$38.36
-$25.00M
Apr 02, 2021
3.78M
Sale
Mar 31
Form 4
200.00K
$25.00
$5.00M
Dec 15, 2020
4.43M
Purchase
Dec 11
Form 4
1.37%
51.37K
$18.34
$941.96K
Sep 23, 2020
4.23M
Purchase
Sep 21 - Sep 23
Form 4
0.21%
7.74K
$18.77
$145.23K
Sep 10, 2020
4.18M
Purchase
Sep 04
Form 4
0.96%
35.62K
$18.71
$666.48K
Sep 01, 2020
4.16M
Purchase
Aug 28 - Sep 01
Form 4
0.77%
28.18K
$19.41
$546.65K
Aug 25, 2020
4.13M
Purchase
Aug 21 - Aug 25
Form 4
0.31%
6.16K
$19.47
$120.00K
Aug 20, 2020
4.06M
Purchase
Aug 18 - Aug 20
Form 4
1.40%
27.02K
$18.46
$498.74K
Aug 14, 2020
4.06M
Purchase
Aug 12 - Aug 14
Form 4
52.51%
1.25M
$13.00
$16.29M
Apr 17, 2020
4.03M
Options
Apr 15
Form 4
0.65%
8.26K
$17.20
$142.13K
Mar 27, 2020
2.78M
Purchase
Mar 25
Form 4
0.35%
4.44K
$14.52
$64.47K
Mar 20, 2020
2.77M
Purchase
Mar 18
Form 4
10.31%
118.28K
$17.94
$2.12M
Mar 17, 2020
2.77M
Purchase
Mar 13 - Mar 17
Form 4
9.53%
373.19K
$22.00
$18.60M
Dec 20, 2019
4.53M
Purchase
Dec 18 - Dec 19
Form 4
3.88%
27.91K
$14.63
$408.23K
May 14, 2019
1.80M
Purchase
May 10 - May 14
Form 4
3.70%
25.68K
$28.63
$406.79K
Dec 19, 2018
1.78M
Purchase
Dec 14 - Dec 18
Form 4
5.55%
36.46K
$14.46
$527.24K
Dec 13, 2018
1.75M
Purchase
Dec 11 - Dec 13
Form 4
10.24%
61.02K
$14.71
$897.45K
Dec 10, 2018
1.71M
Purchase
Dec 06 - Dec 10
Form 4
1.67%
9.80K
$14.91
$146.14K
Dec 04, 2018
1.65M
Purchase
Nov 30 - Dec 04
Form 4
5.34%
29.70K
$15.10
$448.48K
Nov 29, 2018
1.64M
Purchase
Nov 27 - Nov 29
Form 4
14.92%
72.25K
$14.17
$1.02M
Nov 21, 2018
1.61M
Purchase
Nov 19 - Nov 21
Form 4
7.07%
31.99K
$13.48
$431.35K
Nov 19, 2018
1.54M
Purchase
Nov 15 - Nov 16
Form 3
Feb 21, 2017
1.50M
Showing 28 results

Xenon Pharmaceuticals Inc.

Investor
Updated Jun 30, 2017
Form 4/A
2.94%
85.46K
$3.04
$259.47K
Jun 30, 2017
2.99M
Purchase
Jun 27
Form 3
Sep 12, 2016
2.50M
Showing 2 results

Cullinan Oncology, Inc.

Investor
Updated Jan 19, 2023
Form 4
-77.67%
-5.76M
Jan 19, 2023
1.66M
Disposition
Jan 19
Form 4
11.27%
751.40K
$11.00
$8.26M
Jun 03, 2022
7.42M
Purchase
Jun 01
Form 4
19.98%
1.11M
$9.09
$10.06M
May 16, 2022
6.66M
Purchase
May 12 - May 13
Form 4
5.55%
276.00K
$10.75
$2.97M
Apr 05, 2022
5.55M
Purchase
Apr 01
Form 3
Jan 10, 2022
5.28M
Showing 5 results

Merus N.V.

Investor
Updated Oct 08, 2021
Form 4
-22.78%
-1.13M
$27.56
-$31.22M
Oct 08, 2021
3.84M
Sale
Oct 07 - Oct 08
Form 4
-30.54%
-2.19M
$20.75
-$45.36M
Jul 07, 2021
4.97M
Sale
Jul 02
Form 4
4.37%
300.00K
$19.75
$5.93M
Apr 01, 2021
7.16M
Purchase
Mar 30
Form 4
1.99%
79.50K
$22.75
$1.81M
Mar 24, 2021
6.86M
Purchase
Mar 22
Form 4
3.83%
250.00K
$23.00
$5.75M
Mar 18, 2021
6.78M
Purchase
Mar 16
Form 4
14.86%
844.68K
$24.75
$20.91M
Jan 25, 2021
6.53M
Purchase
Jan 21
Form 4
3.11%
160.00K
$16.05
$2.57M
Dec 22, 2020
5.68M
Purchase
Dec 18
Form 4
2.73%
146.75K
$11.75
$1.72M
Sep 17, 2020
5.52M
Purchase
Sep 15
Form 4
3.66%
189.65K
$11.10
$2.10M
Sep 14, 2020
5.38M
Purchase
Sep 10
Form 4
4.05%
201.91K
$11.17
$2.26M
Sep 08, 2020
5.19M
Purchase
Sep 03
Form 4
1.78%
87.25K
$15.20
$1.33M
Jun 10, 2020
4.99M
Purchase
Jun 08
Form 4
42.57%
1.46M
$14.00
$20.48M
Jun 03, 2020
4.90M
Purchase
Jun 01
Form 4
8.83%
278.73K
$16.15
$4.50M
Jan 21, 2020
3.44M
Purchase
Jan 16
Form 4
2.73%
83.96K
$14.98
$1.26M
Jan 15, 2020
3.16M
Purchase
Jan 13
Form 3
Jan 13, 2020
3.07M
Showing 15 results

Nivalis Therapeutics, Inc.

Investor
Updated Jun 22, 2017
Form 4
0.89%
17.81K
$2.25
$40.06K
Jun 22, 2017
2.03M
Purchase
Jun 20
Form 4
1.86%
72.65K
$2.29
$166.07K
Jun 07, 2017
3.98M
Purchase
Jun 05 - Jun 07
Form 4
1.24%
47.00K
$2.28
$106.53K
Jun 01, 2017
3.85M
Purchase
May 30 - May 31
Form 4
1.42%
78.86K
$2.30
$181.32K
May 19, 2017
5.62M
Purchase
May 17 - May 19
Form 4
2.08%
109.03K
$2.33
$253.43K
May 11, 2017
5.36M
Purchase
May 09 - May 11
Form 3
May 11, 2017
1.70M
Showing 6 results

Repare Therapeutics Inc.

Investor
Updated Nov 17, 2023
Form 4
6.52%
1.23M
$5.19
$6.25M
Nov 17, 2023
20.04M
Purchase
Nov 15 - Nov 16
Form 4
9.61%
783.71K
$3.60
$2.82M
Nov 03, 2023
8.94M
Purchase
Nov 02
Form 4
1.86%
149.16K
$12.73
$1.90M
Jun 15, 2022
8.16M
Purchase
Jun 13
Form 4
29.77%
1.84M
$11.90
$21.86M
Jun 06, 2022
8.01M
Purchase
Jun 02 - Jun 06
Form 4
7.30%
420.00K
$8.50
$3.57M
May 20, 2022
6.17M
Purchase
May 18
Form 4
21.00%
997.96K
$14.10
$14.07M
Jan 21, 2022
5.75M
Purchase
Jan 19
Form 3
Nov 08, 2021
4.75M
Showing 7 results

PIERIS PHARMACEUTICALS, INC.

Investor
Updated May 22, 2023
Form 3
May 22, 2023
20.33M
Form 4
-1.00%
-50.00K
$4.50
-$224.97K
Sep 10, 2019
7.31M
Sale
Sep 06
Form 3
Sep 10, 2019
4.98M
Form 4
-72.48%
-5.00M
Feb 01, 2019
4.27M
Disposition
Jan 30
Form 3
Nov 26, 2018
6.89M
Showing 5 results

Verastem, Inc.

Investor
Updated Feb 07, 2022
Form 3
Feb 07, 2022
19.63M
Showing 1 results

Syndax Pharmaceuticals Inc

Investor
Updated Jun 20, 2018
Form 4
Jun 20, 2018
2.90M
Acq/Dis
Jun 18
Form 3
Dec 08, 2017
2.90M
Showing 2 results

CTI BIOPHARMA CORP

Investor
Updated Jun 28, 2023
Form 4
-100.00%
-9.33M
$9.10
-$80.59M
Jun 28, 2023
Disposition
Jun 26
Form 4
80.00K
Apr 07, 2023
9.33M
Grant
Apr 05
Form 4
-1.45%
-129.24K
$6.12
-$52.02M
Aug 11, 2022
9.25M
Sale
Aug 09
Form 4
80.00K
Mar 11, 2022
9.38M
Grant
Mar 09
Form 4
35.51%
2.00M
$275.90
$5.08M
Apr 05, 2021
9.30M
Purchase
Apr 01
Form 4
80.00K
Mar 12, 2021
7.30M
Grant
Mar 10
Form 4
85.30%
1.92K
Mar 04, 2020
6.95M
Purchase
Mar 02 - Mar 04
Form 4
-19.25%
-1.65M
$3.00
$19.00M
Feb 12, 2018
6.94M
Disposition
Feb 09
Form 4
91.78%
4.12M
Jun 14, 2017
8.60M
Purchase
Jun 09
Form 4
1.41%
1.00M
$1.22
$1.22M
Jan 11, 2016
72.02M
Purchase
Jan 07 - Jan 08
Form 3
Dec 14, 2015
43.80M
Showing 11 results

IDEAYA Biosciences, Inc.

Investor
Updated Feb 04, 2021
Form 4
-1.49%
-46.41K
$18.00
-$835.36K
Feb 04, 2021
3.06M
Sale
Feb 02
Form 4
0.08%
2.53K
$13.32
$33.70K
Jul 02, 2020
3.11M
Purchase
Jun 30
Form 4
1.94%
118.00K
$14.16
$1.69M
Jun 22, 2020
6.19M
Purchase
Jun 19 - Jun 22
Form 3
Jun 22, 2020
2.99M
Showing 4 results

CYTOKINETICS INC

Investor
Updated Dec 11, 2020
Form 4
-5.77%
-430.95K
$18.00
-$7.76M
Dec 11, 2020
7.03M
Sale
Dec 09
Form 3
Dec 04, 2020
7.47M
Form 4
-100.00%
-1.38K
Nov 20, 2020
7.07M
Disposition
Nov 20
Form 3
Nov 16, 2020
7.07M
Form 4
-15.36%
-1.07M
$15.79
-$16.92M
Feb 18, 2020
5.91M
Sale
Feb 13
Form 4
2.53%
342.07K
$9.46
$3.23M
Dec 12, 2019
13.84M
Purchase
Dec 10 - Dec 11
Form 3
Dec 12, 2019
6.64M
Showing 7 results

Kymera Therapeutics, Inc.

Investor
Updated Aug 22, 2024
Form 4
358.29K
$40.75
$14.60M
Aug 22, 2024
6.49M
Purchase
Aug 20
Form 4
16.00K
Jun 28, 2024
6.13M
Grant
Jun 18
Form 4
979.01K
$25.25
$24.72M
Jan 09, 2024
6.12M
Purchase
Jan 05
Form 4
4.36%
414.11K
$12.85
$5.30M
Nov 06, 2023
10.00M
Purchase
Nov 02 - Nov 03
Form 4
12.00K
Jun 20, 2023
4.72M
Grant
Jun 15
Form 4
0.47%
41.01K
$30.57
$1.25M
Jan 13, 2023
9.08M
Purchase
Jan 11 - Jan 12
Form 4
13.46%
545.52K
$26.00
$14.18M
Aug 23, 2022
4.67M
Purchase
Aug 22
Form 4
12.00K
Jun 17, 2022
4.13M
Grant
Jun 15
Form 4
7.69%
289.43K
$14.34
$4.15M
May 31, 2022
4.11M
Purchase
May 26 - May 27
Form 4
0.27%
10.10K
$14.00
$141.39K
May 24, 2022
3.83M
Purchase
May 20
Form 4
7.13%
250.00K
$19.45
$4.87M
May 09, 2022
3.81M
Purchase
May 05 - May 06
Form 4
4.12%
130.31K
$38.96
$5.08M
Jan 31, 2022
3.56M
Purchase
Jan 27 - Jan 31
Form 4
9.43%
272.77K
$37.76
$10.30M
Jan 26, 2022
3.43M
Purchase
Jan 24
Form 4
21.28%
544.17K
$47.00
$25.58M
Jul 06, 2021
3.16M
Purchase
Jul 01
Form 4
20.06K
Jun 21, 2021
2.62M
Grant
Jun 16
Form 4
-0.03%
-661.00
$20.00
Aug 25, 2020
2.60M
Options
Aug 20 - Aug 21
Form 3
Aug 25, 2020
Showing 17 results

Calithera Biosciences, Inc.

Investor
Updated May 26, 2020
Form 4
-24.71%
-2.28M
$6.00
-$13.70M
May 26, 2020
6.96M
Sale
May 21
Form 4
2.12%
191.95K
$3.91
$750.85K
Nov 22, 2019
9.24M
Purchase
Nov 20
Form 4
1.44%
128.49K
$3.37
$433.00K
Nov 18, 2019
9.05M
Purchase
Nov 14
Form 4
16.36%
2.40M
$2.65
$6.31M
Oct 31, 2019
17.05M
Purchase
Oct 29 - Oct 30
Form 3
Jul 01, 2019
6.53M
Showing 5 results

CONCERT PHARMACEUTICALS, INC.

Investor
Updated Jun 12, 2019
Form 4
-14.37%
-386.29K
$10.70
-$4.13M
Jun 12, 2019
2.30M
Sale
Jun 10
Form 3
Apr 02, 2019
2.69M
Form 4
-42.92%
-1.28M
$26.65
-$34.19M
Dec 21, 2017
1.71M
Sale
Dec 19
Form 4
12.49%
331.92K
$15.84
$5.26M
Oct 23, 2017
2.99M
Purchase
Oct 19
Form 3
Sep 29, 2017
2.66M
Showing 5 results

CytomX Therapeutics, Inc.

Investor
Updated Feb 18, 2021
Form 4
Feb 18, 2021
5.47M
Form 3
Dec 28, 2020
5.47M
Showing 2 results

MoonLake Immunotherapeutics

Investor
Updated Jun 10, 2024
Form 4
7.69K
Jun 10, 2024
21.71M
Grant
Jun 06
Form 4
11.30K
Jun 12, 2023
21.70M
Grant
Jun 08
Form 3
Apr 15, 2022
21.69M
Showing 3 results

GLYCOMIMETICS INC

Investor
Updated Nov 06, 2020
Form 4
15.72%
1.27M
$2.60
$3.29M
Nov 06, 2020
9.32M
Purchase
Nov 04
Form 4
13.09%
932.61K
$2.75
$2.56M
Nov 03, 2020
8.06M
Purchase
Oct 30
Form 4
30.59%
1.67M
$3.18
$5.31M
Sep 09, 2019
7.12M
Purchase
Sep 05
Form 3
Aug 26, 2019
5.46M
Form 3
May 11, 2017
3.02M
Showing 5 results

Principia Biopharma Inc.

Investor
Updated Aug 20, 2020
Form 4
4.63%
2.27K
$35.79
$81.17K
Aug 20, 2020
51.20K
Purchase
Aug 18
Form 3
Aug 20, 2020
Showing 2 results

INFINITY PHARMACEUTICALS, INC.

Investor
Updated Feb 19, 2021
Form 4
Feb 19, 2021
8.26M
Form 4
-21.48%
-2.26M
$5.37
-$12.13M
Feb 16, 2021
8.26M
Sale
Feb 11
Form 4
-35.72%
-5.85M
$4.14
-$24.21M
Jan 26, 2021
10.52M
Sale
Jan 22
Form 4
1.17%
175.00K
$1.20
$209.91K
Dec 17, 2018
16.37M
Purchase
Dec 13
Form 4
1.56%
100.00K
$1.30
$130.00K
Nov 30, 2018
16.20M
Purchase
Nov 28
Form 4
3.65%
1.47M
$1.36
$2.01M
Nov 21, 2018
41.78M
Purchase
Nov 19 - Nov 21
Form 4
2.32%
905.93K
$1.35
$1.22M
Nov 15, 2018
41.15M
Purchase
Nov 13 - Nov 15
Form 4
17.08%
3.94M
$1.65
$6.50M
Jun 21, 2018
27.02M
Purchase
Jun 19 - Jun 21
Form 4
8.86%
1.51M
$1.95
$2.97M
Apr 11, 2018
18.55M
Purchase
Apr 09 - Apr 10
Form 4
11.20%
1.60M
$1.26
$2.01M
Oct 05, 2017
15.88M
Purchase
Oct 03 - Oct 04
Form 4
0.07%
4.38K
$1.34
$5.87K
Jan 05, 2017
6.67M
Purchase
Jan 03
Form 4
6.25%
742.40K
$1.34
$991.57K
Dec 30, 2016
12.63M
Purchase
Dec 28 - Dec 30
Form 4
3.88%
654.92K
$1.33
$855.49K
Dec 20, 2016
17.52M
Purchase
Dec 16 - Dec 20
Form 4
1.96%
201.39K
$1.19
$238.85K
Dec 02, 2016
10.48M
Purchase
Dec 01 - Dec 02
Form 3
Dec 02, 2016
5.07M
Showing 15 results

Eledon Pharmaceuticals, Inc.

Investor
Updated Oct 31, 2024
Form 4
48.84%
4.75M
$3.65
$17.35M
Oct 31, 2024
27.25M
Purchase
Oct 29
Form 4
183.29%
7.86M
May 13, 2024
22.50M
Purchase
May 09
Form 4
500.86%
11.57M
May 09, 2023
14.64M
Purchase
May 05
Form 3
Jan 31, 2022
2.31M
Form 4
401.10%
1.27M
Dec 28, 2020
1.74M
Options
Dec 22
Form 3
Oct 05, 2020
193.93K
Showing 6 results

Olema Pharmaceuticals, Inc.

Investor
Updated Jun 18, 2024
Form 4
23.00K
Jun 18, 2024
9.05M
Grant
Jun 14
Form 4
22.02%
1.61M
$9.84
$14.82M
Sep 14, 2023
9.03M
Purchase
Sep 12 - Sep 14
Form 4
21.52K
Jun 21, 2023
7.42M
Grant
Jun 16
Form 4
3.02%
200.00K
$4.03
$806.90K
Jun 14, 2022
7.38M
Purchase
Jun 10
Form 4
11.64%
739.67K
$9.39
$6.95M
Dec 02, 2021
7.18M
Purchase
Nov 30
Form 4
99.56K
May 26, 2021
6.52M
Acq/Dis
Mar 31
Form 4
23.00%
1.20M
$19.00
Nov 20, 2020
6.42M
Purchase
Nov 18 - Nov 19
Form 3
Nov 19, 2020
Showing 8 results

Regulus Therapeutics Inc.

Investor
Updated Nov 27, 2017
Form 3
Nov 27, 2017
11.11M
Showing 1 results

ESSA Pharma Inc.

Investor
Updated Jul 21, 2022
Form 3
Jul 21, 2022
8.56M
Showing 1 results

4D Molecular Therapeutics, Inc.

Investor
Updated Aug 01, 2024
Form 3
Aug 01, 2024
7.26M
Form 3
Jun 27, 2022
3.91M
Showing 2 results

Third Harmonic Bio, Inc.

Investor
Updated Oct 31, 2024
Form 4
-23.05%
-1.00M
$14.30
-$14.30M
Oct 31, 2024
3.34M
Sale
Oct 29
Form 4
5.19%
214.06K
$4.11
$879.50K
Dec 22, 2022
4.34M
Purchase
Dec 20
Form 3
Dec 22, 2022
4.12M
Showing 3 results

FIVE PRIME THERAPEUTICS, INC.

Investor
Updated Mar 08, 2021
Form 3
Mar 08, 2021
6.26M
Form 4
-85.66%
-7.39M
$20.19
-$149.25M
Nov 13, 2020
1.24M
Sale
Nov 11
Form 4
5.46%
446.56K
$4.89
$2.18M
Nov 06, 2020
8.63M
Purchase
Nov 04 - Nov 06
Form 4
4.40%
345.24K
$5.04
$1.74M
Oct 08, 2020
8.18M
Purchase
Oct 06
Form 4
0.01%
32.00
$3.80
$121.56
Sep 24, 2020
7.84M
Purchase
Sep 22
Form 4
3.89%
293.59K
$4.10
$1.20M
May 18, 2020
7.84M
Purchase
May 14
Form 4
7.33%
515.02K
$4.05
$2.09M
Dec 26, 2019
7.55M
Purchase
Dec 20
Form 4
1.96%
135.00K
$4.02
$542.36K
Dec 11, 2019
7.03M
Purchase
Dec 09
Form 4
19.39%
1.12M
$3.40
$3.81M
Nov 26, 2019
6.90M
Purchase
Nov 22
Form 4
20.14%
968.11K
$4.00
$3.87M
Nov 07, 2019
5.78M
Purchase
Nov 05
Form 4
0.20%
29.31K
$3.88
$113.81K
Oct 31, 2019
14.39M
Purchase
Oct 29 - Oct 31
Form 4
1.81%
169.37K
$3.75
$634.32K
Oct 25, 2019
9.53M
Purchase
Oct 23 - Oct 25
Form 4
4.78%
601.48K
$3.72
$2.25M
Oct 08, 2019
13.18M
Purchase
Oct 04 - Oct 08
Form 3
Oct 02, 2019
4.01M
Showing 14 results

Structure Therapeutics Inc.

Investor
Updated May 12, 2023
Form 4
May 12, 2023
12.58M
Acq/Dis
May 10
Form 3
Feb 13, 2023
12.58M
Showing 2 results

ARQULE INC

Investor
Updated Jun 01, 2018
Form 4
-10.71%
-1.04M
$5.00
-$5.18M
Jun 01, 2018
10.86M
Sale
May 30
Form 4
-18.73%
-2.23M
$3.10
-$6.91M
Apr 20, 2018
11.90M
Sale
Apr 18
Form 4
-16.20%
-2.30M
$2.90
-$6.67M
Apr 06, 2018
14.13M
Sale
Apr 04
Form 3
Oct 20, 2017
14.21M
Showing 4 results

enGene Holdings Inc.

Investor
Updated Nov 13, 2023
Form 3
Nov 13, 2023
2.22M
Showing 1 results

POINT Biopharma Global Inc.

Investor
Updated Dec 20, 2023
Form 4
-100.00%
-17.16M
$12.45
-$213.66M
Dec 20, 2023
Sale
Dec 18
Form 3
Nov 06, 2023
17.16M
Showing 2 results